Langzeitergebnisse bei der Resektionsbehandlung idiopathischer Bronchiektasien

Spath, F; Finsterbusch, W

doi:10.1007/bf01238411

Cited by 4 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies reported surgical treatment for non-CF bronchiectasis was relatively rare in developed countries 15 23 26 37 38 39 40 41 42 43 44 45 , especially after the year of 2001, only three studies reported 15 23 26 . A possibility is that with the improvements in medical treatment and health insurance, the incidence of non-CF bronchiectasis is decreased in developed countries.…”

Section: Discussionmentioning

confidence: 99%

“…Besides medical treatment and respiratory physiotherapy, surgical treatment is an eligible therapy for patients with non-CF bronchiectasis, especially to those with little response to conservative interventions 7 . Over the years, many studies have reported surgical intervention in the management of patients with non-CF bronchiectasis 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 . The surgical procedure was aimed at primary resection of the affected area, as assessed by high-resolution computed tomographic (HRCT).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Efficiency and safety of surgical intervention to patients with Non-Cystic Fibrosis bronchiectasis: a meta-analysis

Fan

Liang

et al. 2015

Sci Rep

View full text Add to dashboard Cite

No quantitative systematic review was found to report the efficiency and safety of surgical resection in the management of non-cystic fibrosis (non-CF) bronchiectasis. We therefore conducted a meta-analysis to assess the effects of operative intervention to patients with non-CF bronchiectasis. PubMed, the Cochrane library and Web of Science databases were searched up to July 8th, 2015. The pooled mortality from 34 studies recruiting 4788 patients was 1.5% (95% CI, 0.9–2.5%). The pooled morbidity from 33 studies consisting of 4583 patients was 16.7% (95% CI, 14.8–18.6%). The pooled proportion of patients from 35 studies, consisting of 4614 patients who were free of symptoms was 66.5% (95% CI, 61.3–71.7%) after surgery. The summary proportion of patients from 35 articles including 4279 participants who were improved was 27.5% (95% CI, 22.5–32.5%), and 9.1% (95% CI, 7.3–11.5%) showed no clinical improvement. In conclusion, our analysis indicated that lung resection in the management of non-CF bronchiectasis is associated with significant improvements in symptoms, low risk of mortality and acceptable morbidity.

show abstract